Gizzo S

No ORCID on file · 18 papers in corpus
other 2017
Oncology letters ·doi:10.3892/ol.2016.5493

The lethality of epithelial ovarian cancer (EOC) may be due to common misconceptions regarding etiology and the absence of effective screening and early diagnostic tools. Reviews of histopathological surveys performed on the resected fallop…

meta-analysis 2016
Journal of ovarian research ·doi:10.1186/s13048-016-0284-1

Salpingectomy is largely used in case of hydrosalpinx in infertile women scheduled for assisted reproductive technologies (ART), whereas there is no consensus on its role in absence of hydrosalpinx. The current is a systematic literature re…

other 2015
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-015-0588-x

PURPOSE: The aim of the present study was to evaluate the in vivo immunomodulatory effects of an acute short-term estradiol (E(2)) increase on serum levels of B cell-activating factor (BAFF), immunoglobulins (Ig), anti-nuclear antibodies (A…

observational 2015
Oncology letters ·doi:10.3892/ol.2015.4032

The aim of the current study was to diagnose the concomitant presence of adenomyosis (AM) in endometrioid endometrial cancer (EEC) in order to evaluate its value as an oncological prognostic marker. A retrospective analysis of 289 patients …

observational 2015
Archives of gynecology and obstetrics ·doi:10.1007/s00404-014-3591-z

PURPOSE: Restoring the anatomical relationship and preserving the function of pelvic organs represent the ideal outcome of surgical intervention in patients suffering from endometriosis-related infertility. The aim of the study was to compa…

other 2015
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology ·doi:10.1002/uog.14754

It was with great interest that we read the manuscript by Reid et al.1, published recently in the Journal, which proposed a new modified transvaginal ultrasound (TVS) technique (office gel sonovaginography, SVG) with the intention of improv…

observational 2015
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-015-0024-1

BACKGROUND: Aim of the study was to investigate whether menstrual cycle length may be considered as a surrogate measure of reproductive health, improving the accuracy of biochemical/sonographical ovarian reserve test in estimating the repro…

other 2015
Experimental and therapeutic medicine ·doi:10.3892/etm.2015.2734

Controlled ovarian stimulation, using a gonadotrophin-releasing hormone (GnRH) antagonist protocol, is a potential treatment option for women with a low response to other fertility treatments as it appears to be at least as effective as GnR…

rct 2015
Molecular medicine reports ·doi:10.3892/mmr.2015.3904

Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when go…

meta-analysis 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115584446

The aim of the study was to analyze all the available evidence from both in vitro and in vivo studies regarding the efficacy of statin therapy in the treatment of endometriosis, evaluating the potential efficacy, side effects, and contraind…

other 2015
Archives of gynecology and obstetrics ·doi:10.1007/s00404-015-3792-0
meta-analysis 2015
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.05.002

OBJECTIVE: To collate all available evidence with respect to ultrasound techniques in the management of deep pelvic endometriosis (DPE) and compare the sensitivity and specificity of each to determine the most suitable site-specific method.…

other 2014
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.11.018
other 2014
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-014-0412-z
other 2012
PloS one ·doi:10.1371/journal.pone.0044571

BACKGROUND: A variety of indicators of potentially successful ovarian stimulation cycles are available, including biomarkers such as anti-Mullerian hormone. The aim of our study was to confirm the usefulness of serum anti-Mullerian hormone …

review 2011
BMC cancer ·doi:10.1186/1471-2407-11-236

BACKGROUND: Uterine sarcomas are relatively rare tumors that account for approximately 1-3% of female genital tract malignancies and between 4-9% of uterine cancers. Less than 8% of all cases are Mullerian adenosarcoma, a distinctive uterin…

case-report 2011
BMC cancer ·doi:10.1186/1471-2407-11-171

BACKGROUND: Of all female genital tract tumors, 1-3% are stromal malignancies. In 8-10% of cases, these are represented by Müllerian adenosarcoma an extremely rare tumor characterized by a stromal component of usually low-grade malignancy a…

observational 2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.08.043

Endometriosis is a benign gynecologic disease defined as the presence of functional endometrial glands and stroma outside the uterine cavity, causing dysmenorrhea, dyspareunia, menstrual irregularities, and infertility. Serum CA-125 measure…